In February 2015, the US Dietary Guidelines Advisory Committee reported that dietary cholesterol was no longer a “nutrient of concern.” According to the Committee’s report, “available evidence shows no appreciable […]
Month: April 2015
The BMJ Today: Growth charts, depression screening, and a second pair of eyes
• Growth charts reflect a growth in children within India The growth charts committee of the Indian Academy of Paediatrics (IAP) has recently published new growth charts for children aged […]
Julian Sheather: Shaping the ends of our lives
Very difficult to know how we will approach our death until we are in the shadow of it. Will we hold to the ideals we formed when we were healthy, […]
William Cayley: Are you depressed?
“Do you feel down, depressed, or hopeless? Are you bothered by little interest or pleasure in doing things?” Now that the practice I work for is part of an accountable […]
The BMJ Today: Watch, read, listen, do
If you watch one thing today . . . See the two video clips embedded in the “Comptetent Novice” paper “A quick ward assessment of older patients by junior doctors,” and […]
Richard Lehman’s weekly journal review—27 April 2015
NEJM 23 Apr 2015 Vol 372 Last week, dear friends, we kicked off with alirocumab and evolocumab. This week it’s the turn of nivolumab, ipilimumab, and pembrolizumab. It’s driving me […]
Jeffrey Aronson: When I use a word . . . Nose-ography
While editing the forthcoming edition of Meyler’s Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions, I came across a suspected teratogenic effect of high dose oral […]
Maya Annie Elias: Tobacco control in India—more needs to be done to promote smoking cessation in India
Tobacco use is one of the single largest preventable causes of death and a leading risk factor for non-communicable diseases. The burden of tobacco related illnesses prompted the Government of […]
Carlos Martins: Overuse of medical tests—a new health risk factor?
A risk factor is, among other things, an aspect of personal behaviour or lifestyle that, on the basis of epidemiologic evidence, is known to be associated with health related conditions considered important […]
The BMJ Today: Cancer drugs, BMJ awards, and challenges for the NHS
• Donald Light and Joel Lexchin write about the easy ride cancer drugs get in the approval process. They point to three weaknesses: trials on cancer drugs are more often […]